Central Nervous System
Non-pharmacologic strategies superior to drugs for ‘poorly understood’ rheumatic pain
SAN DIEGO — Non-pharmacologic approaches to pain management in rheumatology, like exercise and meditation, can be superior to pharmacologic strategies, according to a speaker at the 2023 Congress of Clinical Rheumatology West.
Dementia diagnosis is ‘underused opportunity’ to reduce polypharmacy
Patients with post-incident dementia were more likely to begin central nervous system medications and less likely to discontinue cardiometabolic and anticholinergic medications, reflecting missed deprescribing opportunities, according to researchers.
Infliximab effective as adjunctive therapy for patients with central nervous system TB
Infliximab was found to be safe and effective as adjunctive therapy for patients with central nervous system tuberculosis, researchers reported.
Central nervous system vasculitis treatment strategies still lack strong data
Current treatment strategies for patients with central nervous system vasculitis are not based on high-grade scientific evidence but rather expert opinion, according to a speaker at the Biologic Therapies Summit.
JCR Pharmaceuticals, Alexion partner to develop novel neurodegenerative therapy
JCR Pharmaceuticals Co. has entered into an agreement with AstraZeneca’s Rare Disease division, Alexion, to develop a novel therapeutic molecule for the treatment of neurodegenerative disease.
Partnership to develop novel stem cell lines for CNS disorders, other neuro conditions
Eterna Therapeutics Inc. announced it has entered into an exclusive option and license agreement with Lineage Cell Therapeutics Inc. to create novel induced hypoimmune pluripotent stem cell lines for use in cell transplant therapies.
Neurological effects of long COVID: It is ‘not only a respiratory disease’
As the world continues to grapple with effects of the COVID-19 pandemic, individuals around the globe are still dealing with symptoms of SARS-CoV-2 infection for months, even years, after their initial infection.
VIDEO: Neurological complications can spur from certain infectious diseases
CHICAGO – Deanna Saylor, MD, MHS, discussed how certain infectious diseases can lead to neurological complications in a presentation at the 2022 American Neurological Association meeting.
FDA approves macrocyclic GBCA for contrast-enhanced MRI
The FDA has approved Elucirem, a macrocyclic gadolinium-based contrast agent for those aged 2 years and older, for use in contrast-enhanced MRIs
FDA approves Xenpozyme, first treatment for rare acid sphingomyelinase deficiency
The FDA has approved Xenpozyme as the first treatment for patients with acid sphingomyelinase deficiency with symptoms unrelated to the central nervous system.